CAMPBELL, Calif., November 3, 2026 – Imperative Care, a medical technology company focused on advancing the treatment of thromboembolic disease, today announced new findings from a pre-specified sex-specific analysis of the SYMPHONY-PE IDE […]
Need help?
Contact usCAMPBELL, Calif., November 3, 2026 – Imperative Care, a medical technology company focused on advancing the treatment of thromboembolic disease, today announced new findings from a pre-specified sex-specific analysis of the SYMPHONY-PE IDE […]